Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Anaesth ; 113(4): 628-33, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24871873

ABSTRACT

BACKGROUND: Postoperative haemorrhage in neurosurgery is associated with significant morbidity and mortality. There is controversy whether or not factor XIII (FXIII) deficiency leads to bleeding complications after craniotomy. Decreased fibrinogen levels have been associated with an increased incidence of bleeding complications in cardiac and orthopaedic surgery. The aim of this study was to assess perioperative fibrinogen and FXIII levels in patients undergoing elective intracranial surgery with and without severe bleeding events. METHODS: Perioperative FXIII and fibrinogen levels were prospectively assessed in 290 patients undergoing elective craniotomy. Patients were divided into two groups according to the presence or absence of severe bleeding requiring surgical revision. Coagulation test results of these groups were compared using Student's t-test. RESULTS: The incidence of postoperative severe bleeding was 2.4%. No differences in FXIII levels were observed, but postoperative fibrinogen levels were significantly lower in patients suffering from postoperative haematoma compared with those without postoperative intracranial bleeding complications [237 mg dl(-1) (standard deviation, SD 86) vs 170 mg dl(-1) (SD 35), P=0.03]. The odds ratio for postoperative haematoma in patients with a postoperative fibrinogen level below 200 mg dl(-1) was 10.02 (confidence interval: 1.19-84.40, P=0.03). CONCLUSIONS: This study emphasizes the role of fibrinogen as potentially modifiable risk factor for perioperative bleeding in intracranial surgery. Future randomized controlled trials will be essential to identify patients who might benefit from fibrinogen substitution during neurosurgical procedures.


Subject(s)
Afibrinogenemia/complications , Coagulation Protein Disorders/complications , Craniotomy/adverse effects , Factor XIII , Postoperative Hemorrhage/epidemiology , Postoperative Hemorrhage/etiology , Adolescent , Adult , Aged , Aged, 80 and over , Blood Coagulation Tests , Confidence Intervals , Female , Fibrinogen/analysis , Fibrinogen/metabolism , Fibrinogen/therapeutic use , Humans , Male , Middle Aged , Neurosurgical Procedures , Odds Ratio , Partial Thromboplastin Time , Platelet Count , Prospective Studies , ROC Curve , Young Adult
2.
Br J Anaesth ; 104(6): 751-5, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20385572

ABSTRACT

BACKGROUND: Caudal anaesthesia is a common procedure for infants and children undergoing subumbilical surgery, mostly performed in conjunction with general anaesthesia. Even if complications are rare, the risk of postoperative apnoea is significant, especially in infants born preterm or operated upon before 46 weeks of post-conceptual age. Caudal block in sedated, spontaneously breathing patients might be a safe alternative. METHODS: We investigated 512 infants and children. Premedication consisted of midazolam, sedation was induced with i.v. nalbuphine 0.1 mg kg(-1) and propofol 1 mg kg(-1), and maintained with propofol 5 mg kg(-1) h(-1) in children, if necessary. Caudal block was performed with ropivacaine 1 ml kg(-1) (0.2% or 0.35%). RESULTS: Data were obtained from 228 infants and 284 children. Median (IQR) age was 1.3 (0.2, 3.4) yr; median body weight was 10.0 (4.8, 15.3) kg. Two hundred and thirty-three (45.51%) were born preterm and 47 (9.18%) were operated upon before 46 weeks of post-conceptual age. Caudal block was successful in 98.05% and adverse events occurred in 7.03% patients. The incidence of adverse events was not higher in born preterm or operated upon before 46 weeks of post-conceptual age than in term born infants (P=0.35 and 0.35, respectively), or in infants vs children (P=0.61). There was no correlation between the incidence of adverse events and continuous sedation (P=0.07), coexisting diseases (P=0.11), or ASA classification (P=0.33). CONCLUSIONS: Caudal anaesthesia under sedation is associated with high success rates and a low incidence of adverse events, but requires careful and anticipatory perioperative management.


Subject(s)
Anesthesia, Caudal/methods , Conscious Sedation/methods , Abdomen/surgery , Analgesics, Opioid , Anesthesia, Caudal/adverse effects , Child , Feasibility Studies , Female , Humans , Hypnotics and Sedatives , Infant , Infant, Newborn , Infant, Premature , Male , Nalbuphine , Premedication/methods , Propofol , Prospective Studies
3.
Mycoses ; 47(3-4): 121-30, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15078428

ABSTRACT

The genus Madurella, described for non-sporulating agents of human mycetoma, is proven to be heterogeneous on the basis of rDNA small subunit (SSU) and Internal Transcribed Spacer (ITS) sequencing data. Madurella mycetomatis, the main agent of mycetoma in arid zones of Central and East Africa, probably belongs to the ascomycete order Sordariales. Madurella mycetomatis, the generic type species, is neotypified. Madurella grisea, with worldwide occurrence, is likely to be a member of the order Pleosporales, just as the mycetoma agents of Leptosphaeria, Pseudochaetosphaeronema, and Pyrenochaeta. Neotestudina rosatii belongs to the order Dothideales. Judging from ITS data, M. mycetomatis and N. rosatii are species complexes. The ex-type strain of N. rosatii, from a human mycetome, has an ITS sequence that deviates from that of environmental strains of the species.


Subject(s)
Madurella/classification , Mycetoma/microbiology , Phylogeny , DNA Primers , DNA, Fungal/analysis , DNA, Ribosomal Spacer/genetics , Humans , Madurella/genetics , Madurella/isolation & purification , Mycological Typing Techniques , Polymerase Chain Reaction , Polymorphism, Restriction Fragment Length
SELECTION OF CITATIONS
SEARCH DETAIL
...